心肺运动试验在左心室辅助技术中的临床应用进展  

Advances in the clinical use of cardiopulmonary exercise testing in left ventricular assist techniques

作　　者：李映雪 王文艳 孔洪 黄克力 于涛 Li Yingxue;Wang Wenyan;Kong Hong;Huang Keli;Yu Tao(School of Medical and Life Sciences,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China;Heart Failure Center,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu 610072,China;Cardiac Surgery Center,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu 610072,China)

机构地区：[1]成都中医药大学医学与生命科学学院,成都610075 [2]四川省医学科学院,四川省人民医院电子科技大学附属医院心衰中心,成都610072 [3]四川省医学科学院,四川省人民医院电子科技大学附属医院心脏外科中心,成都610072

出　　处：《中华胸心血管外科杂志》2023年第11期700-704,共5页Chinese Journal of Thoracic and Cardiovascular Surgery

基　　金：四川省科技计划重点研发项目(2020YFQ0060)。

摘　　要：心肺运动试验是世界上使用最普遍的客观评价心肺储备功能和运动耐力的无创性检查方法,是心力衰竭患者诊断、危险分层、预后评估和制订治疗计划的重要依据。近年来,随着晚期心力衰竭人群逐渐增加,供心数量持续紧张,左心室辅助装置已经由心脏移植的过渡手段逐渐成为其替代性治疗手段。本文针对目前心肺运动试验在评估心力衰竭患者的预后、左心室辅助装置的置入和撤除、术后右心室衰竭及运动康复效果等几个热点问题进行综述。Cardiopulmonary exercise test(CPET)is the most commonly used non-invasive tool in the world to objectively evaluate cardiopulmonary reserve function and exercise tolerance.CPET play an important role in diagnosis,risk stratification,prognosis evaluation and therapeutic planning in heart failure(HF)patients.In recent years,due to the increasing number of advanced HF patients and the paucity of heart donors,left ventricular assist device(LVAD)has represented a valid alternative to heart transplantation(HT)from bridge to transplantation indication to destination therapy.This article summarizes several topical issues regarding the current use of CPET in assessing the prognosis of HF patients,implantation and withdrawal of LVAD,postoperative right ventricular failure,and the effects of exercise rehabilitation in LVAD patients.

关 键 词：心肺运动试验 左心室辅助装置 心力衰竭患者 危险分层 心脏移植 运动耐力 无创性检查 预后评估 

分 类 号：R540.4[医药卫生—心血管疾病]